Vimarsana
Biggest News Aggregation in the World

Page 47 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

Gout: Suboptimal Management a Continuing Problem - Vimarsana News

Gout: Suboptimal Management a Continuing Problem

Although urate-lowering drugs form the cornerstone of gout therapy, there are only three oral medications currently available in the United States, and all have significant limitations.

Semaglutide Cuts Cardiovascular Events in Landmark Trial - Vimarsana News

Semaglutide Cuts Cardiovascular Events in Landmark Trial

Top-line results show semaglutide for weight loss (Wegovy) cut cardiovascular events in the 17,000-person SELECT CV outcomes trial, which should reframe the health benefit of this weight loss drug.

Low-Dose Steroids May Not Increase CV Risk in RA - Vimarsana News

Low-Dose Steroids May Not Increase CV Risk in RA

A daily prednisolone dose of less than 5 mg was not associated with increased cardiovascular risk, whereas a dose of 5 mg or more doubled the risk for major adverse cardiovascular events.

Complications From Geographic Atrophy Drug Fuel Questions - Vimarsana News

Complications From Geographic Atrophy Drug Fuel Questions

An extension study found no cases of occlusive retinal vasculitis after 23,000 injections of pegcetacoplan, but a panel received more reports of the complication and dealt with conflicts of interest.

Using Ozempic for 'Minor' Weight Loss: Fair or Foul? - Vimarsana News

Using Ozempic for 'Minor' Weight Loss: Fair or Foul?

"Are people going to think I'm crazy for doing this?"